GoI increases interval between Covishield doses to 12-16 weeks; says decision ‘science-based’
New Delhi: The Centre Thursday approved extending the gap between the two doses of the Covishield vaccine to 12-16 weeks ...
Read moreDetails
New Delhi: The Centre Thursday approved extending the gap between the two doses of the Covishield vaccine to 12-16 weeks ...
Read moreDetailsChennai: A 40-year-old man who took part in the 'Covishield' vaccine trial here has alleged serious side effects, including a ...
Read moreDetailsNew Delhi: The Drugs Controller General of India (DCGI) has given nod to Serum Institute of India (SII) for conducting ...
Read moreDetailsNew Delhi: Serum Institute of India (SII) has partnered with ‘AstraZeneca’ for manufacturing the Oxford vaccine candidate for COVID-19. Serum ...
Read moreDetails
Protests by thousands of pro-democracy activists in Leh and Kargil districts on 16 March, demanding, among other things, statehood for...
Read moreDetails
The ongoing war between the US-Israel combine and Iran has unexpectedly turned out to be a windfall for Russia. In...
Read moreDetails
The widening conflict in West Asia is beginning to cast a shadow over India’s economic outlook. The country’s heavy dependence...
Read moreDetails
On 4 November 2013, then Prime Minister Manmohan Singh spoke to over 120 heads of Indian missions and outlined the...
Read moreDetails
